COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,362 Articles (22,803 medRxiv, 8,559 bioRxiv)

Most recent first Previous |  Page 1438: Articles 14371-14380  | Next

Integrating PCR-free amplification and synergistic sensing for ultrasensitive and rapid CRISPR/Cas12a-based SARS-CoV-2 antigen detection
Zhao, X., Wang, Z., Yang, B., Li, Z., Tong, Y., Bi, Y., Li, Z., Xia, X., Chen, X., Wang, W., Tan, G.-Y., Zhang, L.
10.1101/2021.06.17.21258275 — Posted: 2021-06-25
A behavioural modelling approach to assess the impact of COVID-19 vaccine hesitancy
Buonomo, B., Della Marca, R., d'Onofrio, A., Groppi, M.
10.1101/2021.06.22.21259324 — Posted: 2021-06-25
Inflection in prevalence of SARS-CoV-2 infections missing the N501Y mutation as a marker of rapid Delta (B.1.617.2) lineage expansion in Ontario, Canada
Brown, K. A., Gubbay, J., Buchan, S. A., Daneman, N., Mishra, S., Patel, S., Day, T.
10.1101/2021.06.22.21259349 — Posted: 2021-06-25
Multi-centre post-implementation evaluation of SARS-CoV-2 antigen-based point of care tests used for asymptomatic screening of continuing care healthcare workers
Kanji, J. N., Proctor, D., Stokes, W., Berenger, B. M., Silvius, J., Tipples, G., Joffe, A. M., Venner, A. A.
10.1101/2021.06.22.21259345 — Posted: 2021-06-25 Discussion: Onsite
Temporal Analysis of Social Determinants Associated with COVID-19 Mortality
Debopadhaya, S., Erickson, J. S., Bennett, K. P.
10.1101/2021.06.22.21258971 — Posted: 2021-06-25
Impact of COVID-19 on deaths from respiratory diseases: Panel Data evidence from Chile.
Barria Sandoval, C., Mendez, A., Ferreia, G., Toffoletto, M. C.
10.1101/2021.06.20.21259216 — Posted: 2021-06-25
Into the thirteenth Month: A Case Study on the Outbreak Analytics and Modeling the spread of SARS-CoV-2 Infection in Pune City, India
Monteiro, J., Pujari, B., Maitra Bhattacharrya, S., Raghunathan, A., Keskar, A., Shaikh, A., Bogam, P., Kadu, S., Raut, N., Vavale, D., Mishra, R., Kembhavi, A., Shashidhara, L. S., Mave, V.
10.1101/2021.06.22.21259295 — Posted: 2021-06-25
Pulmonary thromboembolism in patients after COVID-19 - predictive indicators for correct diagnosis
Yakova-Hristova, D., Simova, I., Pavlov, P., Hristov, M., Kundurzhiev, T., Dimitrov, N., Vekov, T.
10.1101/2021.06.24.21258842 — Posted: 2021-06-25
Potential environmental transmission routes of SARS-CoV-2 inside a large meat processing plant experiencing COVID-19 clusters
de Rooij, M. M. T., Sikkema, R. S., Bouwknegt, M., de Geus, Y., Stanoeva, K. R., Nieuwenweg, S., van Dam, S., Raben, C., Dohmen, W., Heederik, D., Reusken, C., Meijer, A., Koopmans, M., Franz, E., Smit, L.
10.1101/2021.06.20.21259212 — Posted: 2021-06-25
Susceptibility of zero community transmission regimes to new variants of SARS-CoV-2: a modelling study of Queensland
Sanz-Leon, P., Stevenson, N. J., Stuart, R. M., Abeysuriya, R. G., Pang, J. C., Lambert, S. B., Kerr, C. C., Roberts, J. A.
10.1101/2021.06.08.21258599 — Posted: 2021-06-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).